Publicacions en col·laboració amb investigadors/es de Oslo University Hospital (9)

2021

  1. Effect of empagliflozin on exercise ability and symptoms in heart failure patients with reduced and preserved ejection fraction, with and without type 2 diabetes

    European heart journal, Vol. 42, Núm. 6, pp. 700-710

2019

  1. Impact of Renal Impairment on Beta-Blocker Efficacy in Patients With Heart Failure

    Journal of the American College of Cardiology, Vol. 74, Núm. 23, pp. 2893-2904

2018

  1. 2018 Practice guidelines for the management of arterial hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC)

    Blood Pressure, Vol. 27, Núm. 6, pp. 314-340

2016

  1. AIRWAYS-ICPs (European Innovation Partnership on Active and Healthy Ageing) from concept to implementation

    European Respiratory Journal, Vol. 47, Núm. 4, pp. 1028-1033

  2. Continuation of the ESH-CHL-SHOT trial after publication of the SPRINT: Rationale for further study on blood pressure targets of antihypertensive treatment after stroke

    Journal of Hypertension, Vol. 34, Núm. 3, pp. 393-396

  3. Treatment of hypertension and the price to pay; adverse events and discontinuation from randomized treatment in clinical trials

    Journal of Hypertension

2014

  1. Blood pressure and LDL-cholesterol targets for prevention of recurrent strokes and cognitive decline in the hypertensive patient: Design of the European Society of Hypertension-Chinese Hypertension League Stroke in Hypertension Optimal Treatment randomized trial

    Journal of Hypertension, Vol. 32, Núm. 9, pp. 1888-1897

  2. Blood pressure and low-density lipoprotein-cholesterol lowering for prevention of strokes and cognitive decline: A review of available trial evidence

    Journal of Hypertension, Vol. 32, Núm. 9, pp. 1741-1750

  3. Integrated care pathways for airway diseases (AIRWAYS-ICPs)

    European Respiratory Journal, Vol. 44, Núm. 2, pp. 304-323